9 Nov14:58 Business Charles River to buy Frontage’s bioanalysis arm for $470m The Charles River Frontage deal: a $470m cash purchase of bioanalysis and DMPK units, plus a separate $616m take-private of the rest of Frontage. Keith Howard · 1 hr ago